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on September 2006 wholesale acquisition costs (EPO:
$0.01217/Unit, DARB: $4.446/mcg). RESULTS: 439 patients
(296 EPO, 143 DARB) met the entry criteria and formed the
study population. The two groups of patients had similar mean
age (years; EPO 74.9 vs. DARB 74.3) and gender distribution
(female; EPO 51.0% vs. DARB 51.8%). Use of extended dosing
regimens (≥every two weeks [≥Q2W]) was observed in the
majority of patients in both groups (EPO: 71%; DARB: 92%).
The mean (SD) dose per injection was 25,987 (19,298) Units for
EPO and 114.9 (131.1) mcg for DARB. The weighted average
(SD) weekly dose was 13,879 (12,121) Units for EPO and 54.5
(50.2) mcg for DARB, corresponding to an average weekly ery-
thropoietic drug cost of $169 for EPO and $242 for DARB (P
< 0.0001). CONCLUSION: This retrospective claims analysis
reported use of extended dosing (≥Q2W) of both EPO and
DARB in CKD patients aged ≥65 years. Weekly DARB costs
were 43% higher than EPO.
URINARY/KIDNEY—Patient-Reported Outcomes
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OBJECTIVES: To estimate adherence with immunosuppressant
medications in transplant patients served by a group of ﬁve spe-
cialty pharmacies and to assess the medical cost avoidance asso-
ciated with improved adherence, where possible. METHODS:
Prescription ﬁll data were obtained from ﬁve specialty pharma-
cies for Medicare patients who had prescriptions ﬁlled from
January 2005 to June 2005 for one of the following medications:
azathioprine, mycophenolate mofetil, mycophenolic acid, and
sirolimus. Patients were eligible for analysis if they had a pre-
scription ﬁlled in both January and June. Medication possession
ratios (MPRs) were calculated for each medication over the study
period. Patients with MPRs > 0.8 were classiﬁed as adherent. Lit-
erature-based adherence estimates were obtained for compari-
son. The 2005 US Renal Data System Annual Data Report was
used to gather clinical and economic outcome data for a deci-
sion analysis to determine whether differences in adherence
resulted in potential cost avoidance associated with a rejected
renal graft. RESULTS: In the 1599 eligible patients, the estimated
adherence rate was 84.2%, which was signiﬁcantly higher than
the literature-based estimate of 65% (p < 0.01). After applying
the adherence estimates to current Medicare cost estimates for
functioning renal grafts and failed renal grafts, the estimated
yearly cost in study pharmacy patients was $27,853 versus
$32,003 using literature-based adherence estimates—a potential
cost savings of $4150 per patient per year. CONCLUSION:
These ﬁndings suggest that the reduced risk of rejection associ-
ated with increased adherence with immunosuppressant agents
translates into avoidance of signiﬁcant costs associated with
failed renal grafts. Compared to traditional mail-order or retail
pharmacies, the service model used by the study pharmacies
involves high levels of patient contact to promote adherence.
Policies to ensure appropriate reimbursement, such as CMS’s
proposed pay-for-performance framework, would be an impor-
tant step to support and promote optimal patient care.
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OBJECTIVES: Stress urinary incontinence (SUI) is a common
condition in women, caused by anatomical problems related to
factors such as age, parity, white race, hormonal state, higher
educational attainment, pregnancy related factor and higher
body mass index. Several studies indicate obesity as an impor-
tant SUI related factor. This study was conducted to investigate
the impact of obesity in the quality of life of women with urinary
incontinence. METHODS: Women with the symptom of SUI
were recruited prospectively over a 3-months period from a ter-
tiary referral urogynaecology center in a teaching hospital. A
group of 86 women complaining of SUI and conﬁrmed as having
SUI on urodynamic assessment agreed to participate. The King’s
Health Questionnaire (KHQ) was applied before any treatment
to assess the impact of SUI in the quality of life. We then divided
the patients in two groups, obese and non obese women, accord-
ing to their BMI (>30 BMI and <30 BMI) and compared them
using Student t test. RESULTS: There were 25 patients in the
obese group and 61 in the non obese group. There were no sta-
tistical differences between the groups concerning, age, number
of pregnancies, height and daytime frequency. The obese patient
group was heavier (p < 0.0000), with greater BMI (p < 0.0000)
with an also statistically greater nighttime frequency (p =
0.0147). The obese group had more time of SUI symptoms com-
plain (p = 0.0268). Of the evaluated domains of the KHQ
(general health perception, incontinence impact, role limitations,
physical limitations, social limitations, personal relationships,
emotions, sleep/energy, severity measures) only the severity mea-
sures were statistically different among these two groups (p =
0.0093). CONCLUSION: Obesity seems to aggravate the per-
ception of the severity of the urinary incontinence problem in
women.
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OBJECTIVES: The objective of this study was to evaluate the
linguistic validity of 10 translations of the Nocturia Quality of
Life (N-QOL) questionnaire. This self-administered question-
naire was originally developed in English (UK) to measure the
impact of nocturia on health-related quality of life in men with
lower urinary tract symptoms (LUTS), and has since been vali-
dated for use in women. METHODS: Harmonized translations
of the questionnaires were created through an internationally
accepted reiterative process of forward and back translations and
review by a survey research expert and local study users for 
the following languages: Afrikaans (South Africa), Chinese
(Taiwan), English (Canada), English (South Africa), English
(USA), French (Canada), Korean (Korea), Spanish (Mexico),
Swedish (Sweden), and Turkish (Turkey). All translators were
native speakers of the target language and ﬂuent in English (UK).
A diverse sample of 5 subjects in each language reviewed the har-
monized translations and was subsequently debriefed by trained
bilingual interviewers, ﬂuent in both English (UK) and the target
language. A team consisting of the original translators, back
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translator, project manager, interviewer, and survey research
expert evaluated all conceptual, linguistic and stylistic issues that
emerged from the debrieﬁngs. RESULTS: Overall, the transla-
tions were well understood by subjects in all languages. Subjects
in several countries had mild difﬁculty understanding the terms
“Nocturia”, “preoccupied”, and “quality of life”, although these
concepts were translated appropriately in all languages. The term
“concentrate” (“konsantre”) also posed difﬁculty for Turkish
translators and subjects. As there is no other contextually appro-
priate Turkish word for this concept, no change was made to the
Turkish translation. CONCLUSION: The 10 translations of the
NQoL instrument are linguistically and conceptually equivalent
to the original English (UK) questionnaire. Linguistic validation
of the translations will facilitate inter-country comparisons of
nocturia and the pooling of data in multi-country studies.
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OBJECTIVES: The objective of this study was to assess the lin-
guistic validity of 7 translations of the ICIQ-MLUTSsex ques-
tionnaire. This self-administered questionnaire was developed in
English (UK) to measure health-related quality of life, symptom
bother, and the impact of lower urinary tract symptoms on
sexual matters in male patients. METHODS: Harmonized trans-
lations of the questionnaires were created through an inter-
nationally accepted reiterative process of forward and back
translations and review by a survey research expert and local
study users for the following languages: Afrikaans (South
Africa), English (Canada), English (South Africa), English (USA),
Korean (Korea), Slovak (Slovakia), and Spanish (Mexico). All
translators were native speakers of the target language and ﬂuent
in English (UK). A demographically diverse sample of 5 subjects
in each language reviewed the harmonized translations and was
subsequently debriefed by trained bilingual interviewers, ﬂuent
in both English (UK) and the target language. A team consisting
of the original translators, back translator, project manager,
interviewer, and survey research expert evaluated all conceptual,
linguistic and stylistic issues that emerged from the debrieﬁngs.
RESULTS: Overall, the translations were very well understood
by subjects in all languages, although one concept in the ques-
tionnaire caused confusion in two English variants (South Africa
and Canada). Subjects noted the ambiguous referent for “this”,
i.e., whether “this” refers to “sex life” or “no sex life” in the
question “If you have no sex life, how long ago did this stop?”
This ambiguity was not identiﬁed as a problem in the non-
English translations because the translations were constructed to
elicit information about the cessation of sexual activity. CON-
CLUSION: The 7 translations of the ICIQ-MLUTSsex instru-
ment are linguistically and conceptually equivalent to the
original English (UK) questionnaire. Linguistic validation of the
translations will facilitate inter-country comparisons of OAB and
the pooling of data in multi-country studies.
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OBJECTIVES: We assessed changes in health-related quality of
life (HRQoL), resource utilization, work and activity impair-
ment, and health utility among elderly OAB subjects receiving
12 weeks of solifenacin succinate (SOL) therapy, after switching
from tolterodine tartrate extended-release (TOL) due to residual
urgency episodes. METHODS: This was a prospective, multi-
center, open-label US study assessing the efﬁcacy and safety of
SOL in treating OAB. Subjects ≥18 years, who had switched
from TOL to SOL due to residual urgency episodes (≥3/24
hours), with or without urge incontinence, usually with fre-
quency and nocturia, were enrolled. This analysis focused on two
elderly cohorts (65 to 74, and >75 years old). Outcomes were
measured using the Overactive Bladder Questionnaire (OABq),
Work Productivity Assessment Index (WPAI), Medical Care Use
Index (MCUI), and the Health Utilities Index (HUI), adminis-
tered at Pre-Washout (Visit 2) and Post-Washout Week 12 (Visit
7). RESULTS: 103 subjects aged 65 to 74 years and 83 subjects
>75 years met analysis criteria. Subjects in both age groups expe-
rienced signiﬁcant improvement on the OABq symptom bother
scale, all four HRQoL subscales (concern, coping, social inter-
action, sleep) and total HRQoL score. A signiﬁcant reduction in
physician ofﬁce visits was observed in both age groups on the
MCUI, and the 65 to 74 year old age group used signiﬁcantly
fewer pads and diapers. Activity impairment assessed using the
WPAI was also signiﬁcantly reduced in both groups. Although
few subjects were working, those in the 65 to 74 year old group
who were working were signiﬁcantly less impaired by OAB at
work. There were no signiﬁcant differences in HUI scores in
either age group. CONCLUSION: Overall, SOL improved
symptom bother, HRQoL, work productivity, the ability to par-
ticipate in activities, and reduced medical care use in elderly 
subjects with OAB.
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OBJECTIVES: Current guidelines recommend inhaled corticos-
teroids (ICS) as ﬁrst-line therapy in persistent asthma and the
addition of long-acting ß-agonists (LABAs) in patients with mod-
erate-to-severe disease. Our study objective was to assess the
response of high-dose salmeterol/ﬂuticasone combination (SFC)
and low-dose SFC compared to a control group using a vast
array of asthma-related health outcomes in a large cohort of
patients with severe or difﬁcult-to-treat asthma. METHODS:
